Abstract
Recent research on the COVID-19 pandemic suggests that individuals who suffer with serious mental illness (SMI) is at heightened risk of infection and have increased mortality, due to their illness or lack of access to healthcare. As a consequence, progress in developing new treatments for the SMI have been disrupted, with many interruptions and holds places on clinical trials in psychiatry due to concerns regarding the pandemic and its risks to SMI patients.
Full Text
Accepted Version
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call